(Table 3).
Flexor tenosynovitis (Trigger Finger) is characterized by localized
thickening, palpable nodule formation, and triggering during finger
movements in the flexor tendon sheath.19 Yosipovitch
et al. 19 found flexor tenosynovitis to be 5%. In our
study, the frequency of flexor tenosynovitis was found to be 2.8%. In
the literature, there are studies reporting a higher rate of flexor
tenosynovitis. 2,6,11,19 Pandey et al. did not show a
relationship between microvascular complications and flexor
tenosynovitis, and Khader et al. associated retinopathy.9,13 In our study, there was no relationship between
flexor tenosynovitis, neuropathy, and retinopathy, but a significant
association was found with the presence of nephropathy (Table
3).
In patients with diabetes, Charcot arthropathy is a reduction in the
normal afferent protective neural impulses, and therefore loss of
protection from trauma to the joint leads to progressive, painless joint
destruction.20 Charcot arthropathy is found to be in
0.1-5% of patients with diabetes. It is more common in type 2 diabetes
and is equally common in men and women. The incidence increases with the
duration of diabetes.21 In our study, Charcot
arthropathy was found to be 1.7%. In a study published by Agrawal et
al.8, the frequency of Charcot arthropathy was found
to be 2.9%. In the study conducted by Stuck et al.22,
the data of 652 patients with diabetes diagnosed with Charcot
arthropathy were evaluated, and it was emphasized that the duration of
diabetes was associated with Charcot arthropathy. In the same study, the
incidence of Charcot arthropathy increased in patients with neuropathy
and those with HbA1c levels above 7%. In our study, no relationship was
found between metabolic parameters and microvascular complications in
patients diagnosed with Charcot arthropathy.
The frequency of diabetic foot was found to be 6% in our study. In the
study conducted by Ardic et al. 6, the frequency of
diabetes foot was reported to be 6.4% and was associated with
retinopathy. In a study evaluating 811 patients with type 2 diabetes by
Kumar et al.,23 the prevalence of diabetic foot was
found to be 5.3%. In our study, the diabetic foot was associated with
age and duration of diabetes. A significant correlation was shown
between the mean fasting blood glucose and proteinuria levels of the
metabolic parameters and the diabetic foot. The relationship between all
microvascular complications and diabetic foot was observed